The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Human Variability and Noncancer Risk Assessment— An Analysis of the Default Uncertainty Factor
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kay, H. (1980) · Journal of Clinical Pathology · doi:10.1136/jcp.33.6.608-c · Cited by 3,809
Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., & Ham, J. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253358 · Cited by 1,134
Data‐derived safety factors for the evaluation of food additives and environmental contaminants
Renwick, A. G. (1993) · Food Additives and Contaminants · doi:10.1080/02652039309374152 · Cited by 321
Self-citationEvolution of Science-Based Uncertainty Factors in Noncancer Risk Assessment
Dourson, M. L., Felter, S. P., & Robinson, D. (1996) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1996.0116 · Cited by 286
Bertilsson, L., Henthorn, T. K., Sanz, E., Tybring, G., Säwe, J., & Villén, T. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.40 · Cited by 249
Racial Differences in Drug Response
Zhou, H.-H., Koshakji, R. P., Silberstein, D. J., Wilkinson, G. R., & Wood, A. J. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200905 · Cited by 236
Mandona, J. W., Tuk, B., van Steveninck, A. L., Breimer, D. D., Cohen, A. F., & Danhof, M. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.84 · Cited by 229
Evolution of science‐based uncertainty factors in noncancer risk assessment
Dourson, M. L., Felter, S. F., & Robinson, D. (1997) · Human and Ecological Risk Assessment: An International Journal · doi:10.1080/10807039709383713 · Cited by 224
Clinical Pharmacokinetics in Infants and Children A Reappraisal
Kearns, G. L., & Reed, M. D. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198900171-00005 · Cited by 199
Hellriegel, E. T., Bjornsson, T. D., & Hauck, W. W. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90208-8 · Cited by 181
Hoskin, P., Hanks, G., Aherne, G. W., Chapman, D., Littleton, P., & Filshie, J. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05399.x · Cited by 170
Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo
Greenblatt, D. J., Ehrenberg, B. L., Gunderman, J., Locniskar, A., Scavone, J. M., Harmatz, J. S., & Shader, R. I. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.41 · Cited by 168
Clinical Pharmacokinetics of Hydralazine
Ludden, T. M., McNay, J. L., Shepherd, A. M. M., & Lin, M. S. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207030-00001 · Cited by 153
Safety factors and establishment of acceptable daily intakes
RENWICK, A. G. (1991) · Food Additives & Contaminants · doi:10.1080/02652039109373964 · Cited by 146
Self-citationHattis, D. B., Erdreich, L. S., & Ballew, M. (1987) · Risk Analysis · doi:10.1111/j.1539-6924.1987.tb00479.x · Cited by 145
Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation.
Falk, A., Hagberg, M., Löf, A., Tornqvist, E. W., & Wang, Z. P. (1990) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.1771 · Cited by 144
Inter‐subject and ethnic differences in paracetamol metabolism.
Critchley, J., Nimmo, G. R., Gregson, C., Woolhouse, N. M., & Prescott, L. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02953.x · Cited by 140
Capon, D. A., Bochner, F., Kerry, N. L., Mikus, G., Danz, C., & Somogyi, A. A. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90056-9 · Cited by 135
Lindholm, A., Welsh, M. S., Alton, C., & Kahan, B. D. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.156 · Cited by 120
The metabolism of aspirin in man: a population study
Hutt, A. J., Caldwell, J., & Smith, R. L. (1986) · Xenobiotica · doi:10.3109/00498258609043527 · Cited by 119
Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers.
Day, R. O., Graham, G., Bieri, D., et al. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03562.x · Cited by 116
The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin*
Hamelin, B. A., Turgeon, J., Vallée, F., Bélanger, P.-M., Paquet, F., & LeBel, M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90147-2 · Cited by 113
Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain
Inturrisi, C. E., Portenoy, R. K., Max, M. B., et al. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.77 · Cited by 112
Dingemanse, J., Jorga, K. M., Schmitt, M., Gieschke, R., Fotteler, B., Zürcher, G., Prada, M. D., & van Brummelen, P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90035-7 · Cited by 106
Clinical Pharmacokinetics of Metoclopramide
Bateman, D. N. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308060-00003 · Cited by 105
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: A panel study*
Gram, L. F., Guentert, T. W., Grange, S., Vistisen, K. K., & Brøsen, K. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90230-9 · Cited by 100
Ethnic differences in response to morphine
Zhou, H. H., Sheller, J. R., NU, H. E., Wood, M., & Wood, A. J. J. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.182 · Cited by 100
Acceptable daily intake: Inception, evolution, and application
Lu, F. C. (1988) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(88)90006-2 · Cited by 98
Toxicokinetics in infants and children in relation to the ADI and TDI
Renwick, A. G. C. (1998) · Food Additives & Contaminants · doi:10.1080/02652039809374612 · Cited by 91
Self-citationNielsen, K. K., Brøsen, K., Hansen, M. G. J., & Gram, L. F. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.65 · Cited by 91
Hill, H. F., Chapman, C. R., Saeger, L. S., Bjurstrom, R., Walter, M. H., Schoene, R. B., & Kippes, M. E. (1990) · Pain · doi:10.1016/0304-3959(90)90051-e · Cited by 89
Sohn, D., Kwon, J., Kim, H.-K., & Ishizaki, T. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90137-5 · Cited by 89
(1989) · PubMed · Cited by 87
Naumann, B. D., & Weideman, P. A. (1995) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/10807039509380049 · Cited by 80
Uncertainty factors and interindividual variation
Calabrese, E. J. (1985) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(85)90032-7 · Cited by 79
Jejunal permeability and hepatic extraction of fluvastatin in humans
Lindahl, A. H., Sandström, R., Ungell, A.-L. B., Abrahamsson, B., Knutson, T. W., Knutson, L., & Lennernäs, H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90145-9 · Cited by 77
Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.
Graffner, C., Lagerström, P. O., Lundborg, P. G., & Rönn, O. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb01028.x · Cited by 75
Plaud, B., Proost, J. H., Wierda, J. M. K. H., Barre, J., Debaene, B., & Meistelman, C. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90196-5 · Cited by 75
Grapefruit juice—terfenadine single-dose interaction: Magnitude, mechanism, and relevance*
Rau, S. E., Bend, J. R., Arnold, J. M. O., Tran, L. T.-N., Spence, J. D., & Bailey, D. G. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90190-9 · Cited by 68
Coz, F. L., Funck‐Brentano, C., Morell, T., Ghadanfar, M. M., & Jaillon, P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90038-1 · Cited by 63
Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man
Wald, J. A., Law, R. M., Ludwig, E. A., Sloan, R. R., Middleton, E., & Jusko, W. J. (1992) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01064420 · Cited by 62
The concept of the acceptable daily intake: An historical review∗
Truhaut, R. (1991) · Food Additives & Contaminants · doi:10.1080/02652039109373965 · Cited by 60
Lemmens, H. J. M., Dyck, J. B., Shafer, S. L., & Stanski, D. R. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.136 · Cited by 60
The Teratogenic Metabolites of Vitamin A in Women Following Supplements and Liver
Buss, N., Tembe, E. A., Prendergast, B., RENWICK, A. G., & George, C. F. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300106 · Cited by 59
Self-citationMcGourty, J. C., Silas, J. H., Fleming, J. J., et al. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.195 · Cited by 59
Kirch, W., Hutt, H., & Plänitz, V. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01850.x · Cited by 52
Intersubject Variation in the Pharmacokinetics of Haloperidol and Reduced Haloperidol
Midha, K. K., Chakraborty, B. S., GANES, D. A., Hawes, E. M., Hubbard, J. W., Keegan, D. L., Korchinski, E. D., & McKay, G. (1989) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198904000-00005 · Cited by 51
Pharmacokinetics of temafloxacin in humans after single oral doses
Granneman, G. R., Carpentier, P., Morrison, P. J., & Pernet, A. G. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.436 · Cited by 49
The pharmacokinetics of oral nifedipine‐a population study.
Renwick, A., Robertson, D., Macklin, B., Challenor, V., Waller, D., & George, C. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb05256.x · Cited by 47
Self-citationClinical Pharmacokinetics of Newer Cephalosporins
Klepser, M. E., Marangos, M. N., Patel, K. B., Nicolau, D. P., Quintiliani, R., & Nightingale, C. H. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528050-00003 · Cited by 45
Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 AM versus 4 PM
Fisher, L. E., Ludwig, E. A., Wald, J. A., Sloan, R. R., Middleton, E., & Jusko, W. J. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.80 · Cited by 43
IRONS, M. T. K., Lang, C. C., He, H. B., GHEBRESELASIE, K., Shay, S. D., Robin, D. W., & Wood, A. J. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00160.x · Cited by 43
Age, sex, and nitrazepam kinetics: Relation to antipyrine disposition
Greenblatt, D. J., Abernethy, D. R., Locniskar, A., Ochs, H. R., Harmatz, J. S., & Shader, R. I. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.248 · Cited by 39
Does the animal-to-human uncertainty factor incorporate interspecies differences in surface area?
Calabrese, E. J., Beck, B. D., & Chappell, W. R. (1992) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(92)90048-e · Cited by 37
Dias, V. C., Weir, S. J., & Ellenbogen, K. A. (1992) · Circulation · doi:10.1161/01.cir.86.5.1421 · Cited by 37
Racial differences in propranolol pharmacokinetics
Johnson, J. A., & Burlew, B. S. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.53 · Cited by 35
Grahnén, A., Wennerlund, P., Dahlström, B. E., & Eckernas, S. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb03862.x · Cited by 34
SAKASHITA, M., Yamaguchi, T., Miyazaki, H., et al. (1993) · PubMed · Cited by 32
Saotome, T., Minoura, S., Terashi, K., Sato, T., Echizen, H., & Ishizaki, T. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb01933.x · Cited by 32
Grochow, L. B., Noe, D. A., Dole, G., Rowinsky, E. K., Ettinger, D. S., Graham, M. L., McGuire, W. P., & Donehower, R. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.124 · Cited by 32
Plasma concentration — effect relationships for felodipine: A meta analysis
Blychert, E., Edgar, B., Elmfeldt, D., & Hedner, T. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.105 · Cited by 28
Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys
Friedman, H., Redmond, D. E., & Greenblatt, D. J. (1991) · Psychopharmacology · doi:10.1007/bf02244562 · Cited by 24
Tornatore, K. M., Reed, K. A., & Venuto, R. C. (1993) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1993.tb04311.x · Cited by 21
O’Connell, M. B., Pentel, P. R., & Zimmerman, C. L. (1989) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1989.25 · Cited by 18
van Griensven, J. M. T., Jusko, W. J., Lemkes, H. H. P. J., Kroon, R., Verhorst, C. J., Chiang, S. T., & Cohen, A. F. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90019-5 · Cited by 18
Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans
Vree, T. B., Kolmer, E. W. J. E.-B., Wuis, E. W., Hekster, Y. A., & Broekman, M. M. M. (1993) · Pharmacy World & Science · doi:10.1007/bf01880626 · Cited by 17
Patat, A. A., Coz, F. L., Dubruc, C., Gandon, J., Durrieu, G., Cimarosti, I., Jezequel, S., Curet, O., Zieleniuk, I., Allain, H., et al. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04191.x · Cited by 16
Gupta, S. K., Ellinwood, E. H., Nikaido, A. M., & Heatherly, D. G. (1990) · Pharmaceutical Research · doi:10.1023/a:1015805908792 · Cited by 12
Mascher, H. J., & Kikuta, C. (1993) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600820113 · Cited by 12
Hussein, Z., Samara, E. E., Locke, C. S., Orchard, M. A., Ringham, G. L., & Granneman, G. R. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.54 · Cited by 11
Quantification of Theophylline-Induced Eosinopenia and Hypokalaemia in Healthy Volunteers
Braat, M. C. P., Jonkers, R. E., Bel, E. H., & van Boxtel, C. J. (1992) · Clinical Pharmacokinetics · doi:10.2165/00003088-199222030-00005 · Cited by 9
Fleishaker, J. C., Smith, T. C., Friedman, H. L., & Phillips, J. P. (1991) · Psychopharmacology · doi:10.1007/bf02244306 · Cited by 8
Safety and pharmacokinetics of single dose intravenous ofloxacin in healthy volunteers.
Guay, D., Tack, K. J., & Flor, S. C. (1991) · PubMed · Cited by 5
Cited by
Williams, G. M., Kroes, R., & Munro, I. C. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1999.1371 · Cited by 864
RetractedDermal sensitization quantitative risk assessment (QRA) for fragrance ingredients
Api, A. M., Basketter, D. A., Cadby, P. A., Cano, M.-F., Ellis, G., Gerberick, G. F., Griem, P., McNamee, P. M., Ryan, C. A., & Safford, R. (2008) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2007.10.008 · Cited by 336
Hazard characterisation of chemicals in food and diet
Dybing, E., Doe, J., Groten, J., Kleiner, J., O'Brien, J., Renwick, A. G., Schlatter, J., Steinberg, P., Tritscher, A., Walker, R., et al. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(01)00115-6 · Cited by 269
Self-citationArnesdotter, E., Rogiers, V., Vanhaecke, T., & Vinken, M. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1931027 · Cited by 27
Metadata
- Authors
- Renwick, A. G., & Lazarus, N. R.
- Venue
- Regulatory Toxicology and Pharmacology
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 27
- Issue
- 1
- Pages
- 3-20
- ISSN
- 0273-2300 (ISSN-L)
- OpenAlex
- W1979666222
- Cited by
- 261
- References
- 73
- FWCI
- 25.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.